Kim Kunhee, Yim Seung Hyuk, Lee Jae Geun, Joo Dong Jin, Kim Myoung Soo, Park Jun Yong, Ahn Sang Hoon, Kim Deok-Gie, Lee Hye Won
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Department of Surgery, Institute for Transplantation, Yonsei University College of Medicine, Seoul, South Korea.
Aliment Pharmacol Ther. 2025 Jan;61(1):168-176. doi: 10.1111/apt.18335. Epub 2024 Oct 11.
Acute-on-chronic liver failure (ACLF) is a syndrome of patients with chronic liver disease presenting with multiple organ failures. Recently, Sundaram-ACLF-LT Mortality (SALT-M) score has been developed to predict 1-year post-liver transplantation mortality. We validated the SALT-M score in a large-volume, Asian single-centre cohort.
We validated the SALT-M score in a large-volume, Asian single-centre cohort.
We analysed 224 patients of ACLF grade 2-3. Area under the receiver operating characteristic curve (AUROC) and concordance index (c-index) were used to assess and compare the predictability of posttransplant mortality of SALT-M and other scores. Moreover, we compared the survivals of patients with high and low SALT-M, in conjunction with MELD score and ACLF grade.
The AUROC for prediction of 1-year post-LT survival was higher in SALT-M (0.691) than in MELD, MELD-Na, MELD 3.0 and delta-MELD. Similarly, the c-index of the SALT-M (0.650) was higher than aforementioned MELD systems. When categorised by the cut-off of SALT-M ≥ 20 and MELD ≥ 30, patients with high SALT-M exhibited lower post-LT survival than those with low SALT-M scores regardless of high or low MELD (40.0% for high SALT-M/high MELD vs. 42.9% for high SALT-M/low MELD vs. 73.8% for low SALT-M/high MELD vs. 63.7% for low SALT-M/low MELD, p < 0.001). In patients with ACLF grade 3, SALT-M effectively stratified the posttransplant mortality (39.4% for high SALT-M vs. 63.1% for low SALT-M, p = 0.018).
SALT-M outperformed previous MELD systems for predicting posttransplant mortality in Asian LT cohort with severe ACLF. Transplantability for patients with severe ACLF could be determined based on SALT-M.
慢加急性肝衰竭(ACLF)是慢性肝病患者出现多器官功能衰竭的一种综合征。最近,已开发出Sundaram-ACLF-LT死亡率(SALT-M)评分来预测肝移植术后1年的死亡率。我们在一个大容量的亚洲单中心队列中对SALT-M评分进行了验证。
我们在一个大容量的亚洲单中心队列中对SALT-M评分进行了验证。
我们分析了224例2-3级ACLF患者。采用受试者操作特征曲线下面积(AUROC)和一致性指数(c指数)来评估和比较SALT-M及其他评分对移植后死亡率的预测能力。此外,我们结合终末期肝病模型(MELD)评分和ACLF分级,比较了SALT-M高低分组患者的生存率。
SALT-M预测肝移植术后1年生存率的AUROC(0.691)高于MELD、MELD-Na、MELD 3.0和delta-MELD。同样,SALT-M的c指数(0.650)高于上述MELD系统。当以SALT-M≥20和MELD≥30为界值进行分类时,无论MELD高低,SALT-M高分组患者的肝移植术后生存率均低于SALT-M低分组患者(SALT-M高/MELD高为40.0%,SALT-M高/MELD低为42.9%,SALT-M低/MELD高为73.8%,SALT-M低/MELD低为63.7%,p<0.001)。在3级ACLF患者中,SALT-M有效地分层了移植后死亡率(SALT-M高为39.4%,SALT-M低为63.1%,p=0.018)。
在亚洲严重ACLF肝移植队列中,SALT-M在预测移植后死亡率方面优于以往的MELD系统。对于严重ACLF患者,可根据SALT-M来确定其移植可能性。